Eli Lilly and Company (LLY)

Index:

S&P 100

$ 750.78
   
  • Change Today:
    $3.66
  • 52 Week High: $960.02
  • 52 Week Low: $713.71
  • Currency: US Dollars
  • Shares Issued: 948.17m
  • Volume: 3,056,488
  • Market Cap: $711,867m
  • RiskGrade: 179
  • Beta: 0.70

Latest ShareCast News

GSK, AstraZeneca slide after FDA unveils new vaccine lead

By Abigail Townsend

Date: Wednesday 07 May 2025

(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.

Lilly shares jump on positive results from oral weight-loss drug trial

By Benjamin Chiou

Date: Thursday 17 Apr 2025

(Sharecast News) - Shares in Eli Lilly & Co were set to soar on Wednesday on the back of positive results of a late-stage trial of its weight-loss pill Orforglipron, which is thought to be a needle-free alternative to Novo Nordisk's popular injectable Ozempic drug.

Weight-loss drugs swell revenues at Eli Lilly

By Abigail Townsend

Date: Thursday 06 Feb 2025

(Sharecast News) - Eli Lilly and Company posted a surge in fourth-quarter revenues on Thursday, fuelled by strong demand for its blockbuster diabetes and weight-loss drugs.

Eli Lilly weight-loss drug Zepbound beats Wegovy... 04-Dec-2024 ShareCast
Eli Lilly's quarterly numbers disappoint, shares... 30-Oct-2024 ShareCast
Eli Lilly hikes guidance as obesity drug sales s... 08-Aug-2024 ShareCast
Eli Lilly hikes guidance as obesity drug sales s... 08-Aug-2024 ShareCast
Eli Lilly to acquire Morphic via tender offer 08-Jul-2024 ShareCast
Roche sees positive results from weight-loss tri... 16-May-2024 ShareCast
Eli Lilly hikes sales guidance by $2bn, shares j... 30-Apr-2024 ShareCast
Eli Lilly weight-loss drug 'significantly' reduc... 17-Apr-2024 ShareCast
Eli Lilly to buy Point Biopharma in $1.4bn deal 03-Oct-2023 ShareCast
Eli Lilly hikes guidance despite first-quarter e... 27-Apr-2023 ShareCast
Eli Lilly to buy genetic medicine developer Akou... 18-Oct-2022 ShareCast
Eli Lilly misses Q3 estimates, but sales top exp... 26-Oct-2021 ShareCast
Eli Lilly posts slightly weaker than expected Q2... 03-Aug-2021 ShareCast
Eli Lilly buys Protomer Technologies in $1bn deal 14-Jul-2021 ShareCast
Eli Lilly Covid-19 therapy works against new vir... 10-Mar-2021 ShareCast
Eli Lilly therapy shown to reduce death in Covid... 10-Mar-2021 ShareCast
Eli Lilly gets EUA for new antibody 'cocktail', ... 10-Feb-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 750.78
Change Today $ 3.66
% Change 0.49 %
52 Week High $960.02
52 Week Low $713.71
Volume 3,056,488
Shares Issued 948.17m
Market Cap $711,867m
Beta 0.70
RiskGrade 179

What The Brokers Say

Strong Buy 11
Buy 10
Neutral 5
Sell 1
Strong Sell 0
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 03-Jun-2025

Time Volume / Share Price
15:59 119 @ $751.06
15:59 100 @ $750.87
15:59 100 @ $750.87
15:59 100 @ $750.90
15:59 110 @ $751.08

Top of Page